- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
29 Cd19 B Cell Lymphoma Trials Near You
Power is an online platform that helps thousands of Cd19 B Cell Lymphoma patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerAZD0486 for Non-Hodgkin's Lymphoma
Trial Details
Key Eligibility Criteria
317 Participants Needed
Gene Therapy for Acute Lymphoblastic Leukemia
Trial Details
Key Eligibility Criteria
32 Participants Needed
Cell Therapy for Non-Hodgkin's Lymphoma
Trial Details
Key Eligibility Criteria
248 Participants Needed
CAR T-Cell Therapy for Leukemia and Lymphoma
Trial Details
Key Eligibility Criteria
12 Participants Needed
CAR T Cell Therapy for Leukemia
Trial Details
Key Eligibility Criteria
153 Participants Needed
Tafasitamab + Lenalidomide for Diffuse Large B-Cell Lymphoma
Trial Details
Key Eligibility Criteria
899 Participants Needed
CNTY-101 for B-Cell Malignancies
Trial Details
Key Eligibility Criteria
28 Participants Needed
UB-VV111 + Rapamycin for B-Cell Lymphoma
Trial Details
Key Eligibility Criteria
106 Participants Needed
IMPT-314 for Non-Hodgkin's Lymphoma
Trial Details
Key Eligibility Criteria
270 Participants Needed
Cema-cel for B-Cell Lymphoma
Trial Details
Key Eligibility Criteria
250 Participants Needed
Trial Details
Key Eligibility Criteria
30 Participants Needed
CAR-T Cell Therapy + IL-2 for Blood Cancer
Trial Details
Key Eligibility Criteria
36 Participants Needed
CAR NK Cells for B-Cell Cancers
Trial Details
Key Eligibility Criteria
150 Participants Needed
Tafasitamab + Lenalidomide for Non-Hodgkin's Lymphoma
Trial Details
Key Eligibility Criteria
53 Participants Needed
CAR-T Therapy for Non-Hodgkin's Lymphoma
Trial Details
Key Eligibility Criteria
230 Participants Needed
CAR T-Cell Therapy for Lymphoma and Leukemia
Trial Details
Key Eligibility Criteria
30 Participants Needed
SC291 for B-Cell Malignancies
Trial Details
Key Eligibility Criteria
16 Participants Needed
Maplirpacept + Tafasitamab + Lenalidomide for Non-Hodgkin's Lymphoma
Trial Details
Key Eligibility Criteria
6 Participants Needed
CLBR001 CAR-T for Non-Hodgkin's Lymphoma
Trial Details
36 Participants Needed
CAR T-Cell Therapy + Ibrutinib for Chronic Lymphocytic Leukemia
Trial Details
Key Eligibility Criteria
206 Participants Needed
Why Other Patients Applied
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I've been struggling with ADHD and anxiety since I was 9 years old. I'm currently 30. I really don't like how numb the medications make me feel. And especially now, that I've lost my grandma and my aunt 8 days apart, my anxiety has been even worse. So I'm trying to find something new."
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
CAR T-Cell Therapy for Lymphoma and Leukemia
Trial Details
Key Eligibility Criteria
24 Participants Needed
CAR-T Therapy for B-Cell Lymphoma
Trial Details
Key Eligibility Criteria
19 Participants Needed
IKS03 for B-Cell Lymphoma
Trial Details
Key Eligibility Criteria
140 Participants Needed
CAR-T Cell Therapy for B-Cell Lymphoma
Trial Details
Key Eligibility Criteria
30 Participants Needed
CAR T Cell Therapy for Leukemia and Lymphoma
Trial Details
Key Eligibility Criteria
30 Participants Needed
Radioimmunotherapy + CAR T-cell Therapy for Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma
Trial Details
Key Eligibility Criteria
6 Participants Needed
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia
Trial Details
Key Eligibility Criteria
24 Participants Needed
Metabolically Fit CD19 CAR T-Cell Therapy for Non-Hodgkin's Lymphoma and Chronic B-Cell Leukemia
Trial Details
Key Eligibility Criteria
27 Participants Needed
CLIC-1901 CAR-T Therapy for Blood Cancers
Trial Details
Key Eligibility Criteria
60 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Cd19 B Cell Lymphoma clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Cd19 B Cell Lymphoma clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Cd19 B Cell Lymphoma trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Cd19 B Cell Lymphoma is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Cd19 B Cell Lymphoma medical study?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Cd19 B Cell Lymphoma clinical trials?
Most recently, we added CAR T-Cell Therapy for Leukemia and Lymphoma, Gene Therapy for Acute Lymphoblastic Leukemia and UB-VV111 + Rapamycin for B-Cell Lymphoma to the Power online platform.